suggested that exosomal miR-26a from CAFs could facilitate endometrial cancer progression by targeting the signal transducer and activator of the transcription 3/chitinase 3-like 1 signaling pathway (35). This evidence concerns the gene CHI3L1 and endometrial cancer.